糖尿病的药物治疗目前主要有以下几大类:包括噻唑烷二酮类胰岛素增敏剂、磺脲类、非磺脲类促泌剂、糖苷酶抑制剂、双胍类及胰岛素或胰岛素类似物。随着对糖尿病发病机制的不断深入研究,肠促胰岛素类似物、非噻唑烷二酮类(PPARγ)选择性激动剂以及一些新的分子被认为具有潜在的降糖作用,备受人们关注。本文就目前糖尿病药物的新进展做一论述。 At present, the drug treatment of diabetes mainly includes the following categories: thiazolidinedione insulin sensitizers, sulfonylureas, non-sulfonylureas, glycosidase inhibitors, biguanides and insulin or insulin analogues. With the continuous research on the pathogenesis of diabetes, incretin analogs, non-thiazolidinediones (PPARγ) selective agonists and some new molecules are considered to have potential hypoglycemic effects, attracting much attention. This article on the current progress of diabetes drugs to make a discussion.